Paperpal Prime Logo

Bioorganic and Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1464-3405pISSN: 0960-894X

Aims and Scope of Bioorganic and Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q3Biochemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Bioorganic and Medicinal Chemistry Letters

Bioorganic and Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1991
Publisher URLVisit website
View less

Planning to publish in Bioorganic and Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters

Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Site-specific profiling of lysine itaconylation via a thiol-based probe.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
99ᵐTc-DTPA-OM: Cardiac-myosin targeted SPECT agent for non-invasive myocardial infarction imaging.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Site-specific profiling of lysine itaconylation via a thiol-based probe.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
99ᵐTc-DTPA-OM: Cardiac-myosin targeted SPECT agent for non-invasive myocardial infarction imaging.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters
Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment.
  • 1 Nov 2026
  • Bioorganic & medicinal chemistry letters

FAQs on Bioorganic and Medicinal Chemistry Letters